Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00830
Species: Homo sapiens
Position : chr20:44478646-44484559
Year: 2011
Title: Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  21556051
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: PC-3
CVCL ID: CVCL_0035
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; 3C; Western blot
About Target Gene
Target gene : UBE2C
About TF
TF name : POU2F1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU2F1 AndrogenReceptor netpath 167
POU2F1 ATF-2 transcription factor network pid 59
POU2F1 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
POU2F1 Calcium signaling in the CD4+ TCR pathway pid 29
POU2F1 FOXA1 transcription factor network pid 45
POU2F1 Glucocorticoid receptor regulatory network pid 85
POU2F1 Regulation of Androgen receptor activity pid 54
POU2F1 RNA polymerase II transcribes snRNA genes reactome 70
POU2F1 RNA Polymerase III Abortive And Retractive Initiation reactome 41
POU2F1 RNA Polymerase III Transcription Initiation From Type 3 Promoter reactome 28
POU2F1 Hs_Integrated_Cancer_Pathway_WP1971_82939 wikipathways 33
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00823 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00824 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00825 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00826 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00827 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00828 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
E_00829 chr20:44478646-44484559 prostate gland malignant cell prostate cancer
Expression of Target Genes for the Enhancer